Thioguanine in inflammatory bowel disease: Long-term efficacy and safety (Q33731976)

29 July 2017

title

Thioguanine in inflammatory bowel disease: Long-term efficacy and safety (English)

1 reference

inflammatory bowel diseases

29 July 2017

main subject

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Anthony M Marinaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Jeremy D Sanderson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Kamal V Patel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Viraj C Kariyawasam

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Rishi Goel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Ben Warner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Tim R Elliott

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Paul A Blaker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

1 August 2016

1 reference

United European gastroenterology journal

29 July 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

563-570

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.

13 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

6-Thioguanine therapy in Crohn's disease--observational data in Swedish patients.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

Further experience with the use of 6-thioguanine in patients with Crohn's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

6-thioguanine can cause serious liver injury in inflammatory bowel disease patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

A simple clinical colitis activity index

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease

21 June 2018

1 reference

https://api.crossref.org/works/10.1177%2F2050640616663438

A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2050640616663438

Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2050640616663438

Splitting a therapeutic dose of thioguanine may avoid liver toxicity and be an efficacious treatment for severe inflammatory bowel disease: a 2-center observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2050640616663438

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2050640616663438

Use of azathioprine and the risk of cancer in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2050640616663438

Histopathology of liver biopsies from a thiopurine-naïve inflammatory bowel disease cohort: prevalence of nodular regenerative hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2050640616663438

Leucocyte versus erythrocyte thioguanine nucleotide concentrations in children taking thiopurines for acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2050640616663438

Revising the Declaration of Helsinki

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446138

Comparative Effectiveness of Immunosuppressants and Biologics for Inducing and Maintaining Remission in Crohn's Disease: A Network Meta-analysis

30 October 2018

1 reference

https://api.crossref.org/works/10.1177%2F2050640616663438

Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC

21 January 2018

1 reference

12 December 2020

Measuring Crohn's disease activity

1 reference

12 December 2020

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease

1 reference

12 December 2020

Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis

1 reference

12 December 2020

Evaluation of intravenous 6-thioguanine as first-line chemotherapy in women with metastatic breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1177/2050640616663438

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28588888%20AND%20SRC:MED&resulttype=core&format=json